Your browser doesn't support javascript.
loading
TRRAP is essential for regulating the accumulation of mutant and wild-type p53 in lymphoma.
Jethwa, Alexander; Slabicki, Mikolaj; Hüllein, Jennifer; Jentzsch, Marius; Dalal, Vineet; Rabe, Sophie; Wagner, Lena; Walther, Tatjana; Klapper, Wolfram; Bohnenberger, Hanibal; Rettel, Mandy; Lu, Junyan; Smits, Arne H; Stein, Frank; Savitski, Mikhail M; Huber, Wolfgang; Aylon, Yael; Oren, Moshe; Zenz, Thorsten.
Afiliação
  • Jethwa A; Molecular Therapy in Haematology and Oncology, Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Slabicki M; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
  • Hüllein J; Molecular Therapy in Haematology and Oncology, Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Jentzsch M; Molecular Therapy in Haematology and Oncology, Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Dalal V; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
  • Rabe S; Molecular Therapy in Haematology and Oncology, Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Wagner L; Molecular Therapy in Haematology and Oncology, Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Walther T; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
  • Klapper W; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
  • Bohnenberger H; Molecular Therapy in Haematology and Oncology, Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Rettel M; Molecular Therapy in Haematology and Oncology, Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Lu J; Hematopathology Section and Lymph Node Registry, Department of Pathology, University Hospital Schleswig-Holstein, Campus Kiel, Christian Albrechts University Kiel, Kiel, Germany.
  • Stein F; Institute of Pathology, University Medical Center Göttingen, Göttingen, Germany.
  • Savitski MM; European Molecular Biology Laboratory, Heidelberg, Germany.
  • Huber W; European Molecular Biology Laboratory, Heidelberg, Germany.
  • Aylon Y; European Molecular Biology Laboratory, Heidelberg, Germany.
  • Oren M; European Molecular Biology Laboratory, Heidelberg, Germany.
  • Zenz T; European Molecular Biology Laboratory, Heidelberg, Germany.
Blood ; 131(25): 2789-2802, 2018 06 21.
Article em En | MEDLINE | ID: mdl-29653964
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Nucleares / Proteína Supressora de Tumor p53 / Proteínas Adaptadoras de Transdução de Sinal / Linfoma Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Nucleares / Proteína Supressora de Tumor p53 / Proteínas Adaptadoras de Transdução de Sinal / Linfoma Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Alemanha